PD2M this conference connects academia, industry, and government representatives to discuss the current approaches and future directions for process and product development, as well as the manufacturing of biopharmaceuticals beyond the traditional small molecule and antibody/protein CMC.


Important Deadlines:
Abstract Submission Deadline: March 5, 2025
Submit here: https://aiche.confex.com/aiche/pdsdpnm2025/cfp.cgi


Early Bird Rates Deadline: April 1, 2025
Register here: https://www.aiche.org/conferences/new-frontiers-pharmaceutical-drug-substance/2025


SESSION TOPICS:
• Advances in Modalities with Chemical Transformations

(peptides, oligos, ADC conjugations)

• Advances in Cellular Expression and Upstream Productions

• Downstream Processing

• Drug Product Development (Formulation and Delivery)

• Enabling Technologies


Keynotes

Martin D., Eli Lilly and Company

Kelvin Lee, University of Delaware & NIIMBL


Featured Speakers

Steven Cramer, RPI

Tian Jun, WuXi Biologics


Conference Chairs:

Chris Lowe, Takeda Pharmaceuticals

Brian Lowry, AbbVie S&T Biologics

Nil Tandogan-Gray, Eli Lilly

Organizing Committee:

Marian Gindy, Merck

Wai Keen Chung, BMS

Karthik Narsimhan, AbbVie/Immunogen

Ning Liu, Lilly

Sarena Horava, Eli Lilly

Pinky Patel, FDA

Olga Paley, Takeda

Neda Nazemifard, Takeda

Paul Collins, Eli Lilly and Company

John Morgan, Purdue University

Marianthi Ierapetritou, University of Delaware


Conference Organized by Pharmaceutical Discovery, Development and Manufacturing Forum

About PD2M
The Pharmaceutical Discovery, Development and Manufacturing Forum (PD2M) promotes the interchange of ideas, concepts, know-how, and experiences in Pharmaceutical Discovery, Development and Manufacturing with other groups within and outside of the Institute. https://www.aiche.org/community/sites/divisions-forums/pharmaceutical-discovery-development-and-manufacturing-forum-pd2m